Randomized, 2-Way Crossover, Bioequivalence Study of Valacyclovir 1000 mg Tablet and Valtrex Following a 1 x 1000 mg Dose in Healthy Subjects Under Fasting Conditions.

Trial Profile

Randomized, 2-Way Crossover, Bioequivalence Study of Valacyclovir 1000 mg Tablet and Valtrex Following a 1 x 1000 mg Dose in Healthy Subjects Under Fasting Conditions.

Completed
Phase of Trial: Phase I

Latest Information Update: 26 Jun 2010

At a glance

  • Drugs Valaciclovir (Primary)
  • Indications Cytomegalovirus infections; Herpes simplex virus infections; Herpes zoster; Herpesvirus infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 26 Jun 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top